
Programmable biology company for psychoactive effect design
Mindstate Design Labs is building the closed-loop science & engineering stack for rational psychoactive effect design. Our molecular-experience interface links molecular biology to the human psychopharmacodynamic profile to convert informal constructs like clarity, presence, or motivation into high-dimensional design targets. Our clinical program is a sequence of human demonstrations that psychoactive effects can be decomposed, recombined, and synthesized. The first controlled study decomposed hallucinations from the broader hallucinogen profile; the next is designed to selectively upregulate aesthetic salience to treat anhedonia in major depressive disorder. We’re progressively digitizing the molecular interface through which biology shapes what intelligence wants.
Founder/CEO
Ex-VC, F500 M&A. Invested across frontier biology, software, and hardware; founded platforms in programmable genes, proteins, cells, and biological systems (AAV capsids, multispecific antibodies, TCRs, tumor microenvironment, etc.).
Founder
BS in biology & chemistry Florida State University. MS & PhD in biology Harvard, tropical plant ecology. 1981 Society of Fellows U Michigan Ann Arbor. 1981-1998 faculty University Delaware, biology & computer science. 1993-2003 External Faculty of the Santa Fe Institute. 1993-1998 invited researcher ATR (Advanced Telecommunications Research Institute) Human Information Processing Research Labs in Japan. In 1998-present Professor of Biology & Computer Science OU. AAAS Fellow. http://tomray.me/